A comprehensive genomic test reporting structure for communicating cancer and incidental findings

Exome and genome sequencing are increasingly being used in clinical practice for diagnosis and targeted treatments. These technologies allow for the identification of incidental findings (IFs), findings unrelated to the reason for testing. Patient preferences indicate an interest in receiving a broad range of IFs, which creates challenges for the communication of results to patients and health care providers (HCPs). Effective communication of genomic sequencing (GS) results and IFs in clinical practice is essential for patient management.